Stock listing
E2Z Stock Price, News, Filings & Events — Almirall Sa
Selected listing: E2Z · GETTEX · EUR · DE
This page tracks Almirall Sa's E2Z:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following E2Z:GETTEX. E2Z:GETTEX is the stock-level entry point for investors researching Almirall Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Almirall Sa is a publicly traded company on the Spanish market, with a market capitalization of approximately €2.65 billion. The company focuses on the development and commercialization of innovative pharmaceutical products. Almirall is committed to improving patient outcomes through its research and development efforts in various therapeutic areas.

- Ticker
- E2Z:GETTEX
- Asset type
- Stock
- Market cap
- $2.81B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GETTEX
- Currency
- EUR
Almirall Sa E2Z:GETTEX stock context
This page tracks Almirall Sa's E2Z:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following E2Z:GETTEX. E2Z:GETTEX is the stock-level entry point for investors researching Almirall Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Almirall Sa is a publicly traded company on the Spanish market, with a market capitalization of approximately €2.65 billion. The company focuses on the development and commercialization of innovative pharmaceutical products. Almirall is committed to improving patient outcomes through its research and development efforts in various therapeutic areas.
Research Almirall Sa
Almirall Sa investor report
Review AI stock analysis and investor report context for E2Z:GETTEX.
Almirall Sa company profile
View the public company page for Almirall Sa on 6ix.
Almirall Sa news
Read company news and market updates connected to Almirall Sa.
Almirall Sa investor events
Find investor webinars, events, and replay context for Almirall Sa.
Alternate listings
ALM:BME
ES · EUR
Alternate listing for Almirall Sa; the primary context on this page is E2Z:GETTEX.
A0MU8Y:LSX
DE · EUR
Alternate listing for Almirall Sa; the primary context on this page is E2Z:GETTEX.
ALMRY:OTC
US · USD
Alternate listing for Almirall Sa; the primary context on this page is E2Z:GETTEX.
A0MU8Y:LS
DE · EUR
Alternate listing for Almirall Sa; the primary context on this page is E2Z:GETTEX.
ALME:AQUISEU
GB · EUR
Alternate listing for Almirall Sa; the primary context on this page is E2Z:GETTEX.
0O9B:LSIN
GB · EUR
Alternate listing for Almirall Sa; the primary context on this page is E2Z:GETTEX.
LBTSF:OTC
US · USD
Alternate listing for Almirall Sa; the primary context on this page is E2Z:GETTEX.
ALME:AQUISUK
GB · EUR
Alternate listing for Almirall Sa; the primary context on this page is E2Z:GETTEX.
E2Z:TRADEGATE
DE · EUR
Alternate listing for Almirall Sa; the primary context on this page is E2Z:GETTEX.
E2Z:FWB
DE · EUR
Alternate listing for Almirall Sa; the primary context on this page is E2Z:GETTEX.
E2Z0:FWB
DE · EUR
Alternate listing for Almirall Sa; the primary context on this page is E2Z:GETTEX.
ALM:VIE
AT · EUR
Alternate listing for Almirall Sa; the primary context on this page is E2Z:GETTEX.